Literature DB >> 26150570

Dispensing inhalers to patients with chronic obstructive pulmonary disease on hospital discharge: Effects on prescription filling and readmission.

John Blee1, Ryan K Roux1, Stefani Gautreaux1, Jeffrey T Sherer1, Kevin W Garey2.   

Abstract

PURPOSE: The effects of dispensing inhalers to patients with chronic obstructive pulmonary disease (COPD) on hospital discharge were evaluated.
METHODS: Data were collected in 2011-12 for patients with COPD who had hospital orders for the study inhalers (preintervention group) and after implementation of the multidose medication dispensing on discharge (MMDD) service (2013-14) (postintervention group). The primary objective of this study was to assess inhaler adherence and readmission rates before and after MMDD implementation. Adherence was defined as filling the discharge prescription for the multidose inhaler at a Harris Health pharmacy within three days of discharge or having at least seven days of medication left in an inhaler from a previous prescription that was filled or refilled before hospital admission. All patients in the postintervention group were considered adherent, since every patient was given the remainder of his or her multidose inhaler when discharged.
RESULTS: Data from 620 patients (412 in the preintervention group, 208 in the postintervention group) were collected. During the preintervention time period, 88 of 412 patients were readmitted within 30 days compared with 18 of 208 patients during the postintervention period (p < 0.001). The intervention was associated with a significant reduction in 30-day readmissions (p = 0.0016) and 60-day readmissions (p = 0.0056).
CONCLUSION: A targeted pharmacy program to provide COPD patients being discharged from the hospital with the multidose inhalers they had used during hospitalization was associated with improved medication adherence, as measured by prescription filling behavior, and reduced rates of 30- and 60-day hospital readmissions.
Copyright © 2015 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26150570     DOI: 10.2146/ajhp140621

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  6 in total

1.  Evaluation of Bronchodilator Use During Chronic Obstructive Pulmonary Disease Exacerbation Inpatient Admissions.

Authors:  Sarah E Petite; Julie A Murphy
Journal:  Hosp Pharm       Date:  2018-04-10

2.  Factors Associated with Differential Readmission Diagnoses Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Russell G Buhr; Nicholas J Jackson; Steven M Dubinett; Gerald F Kominski; Carol M Mangione; Michael K Ong
Journal:  J Hosp Med       Date:  2020-02-11       Impact factor: 2.960

Review 3.  COPD Readmissions: Addressing COPD in the Era of Value-based Health Care.

Authors:  Tina Shah; Valerie G Press; Megan Huisingh-Scheetz; Steven R White
Journal:  Chest       Date:  2016-05-07       Impact factor: 9.410

4.  Comprehensive and Collaborative Pharmacist Transitions of Care Service for Underserved Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Jennifer Kim; Amy Lin; Randy Absher; Tanya Makhlouf; Casey Wells
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

Review 5.  Predicting and preventing hospital readmission for exacerbations of COPD.

Authors:  Chia Wei Kong; Tom M A Wilkinson
Journal:  ERJ Open Res       Date:  2020-05-11

6.  Evaluating the disease and treatment information provided to patients with chronic obstructive pulmonary disease at the time of discharge according to GOLD discharge guidelines.

Authors:  Letícia de Araújo Morais; Samylla Ysmarrane Ismail Eisha de Sousa Cavalcante; Marcus Barreto Conde; Marcelo Fouad Rabahi
Journal:  Einstein (Sao Paulo)       Date:  2019-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.